Torrent Pharmaceuticals is the pharma arm of the Torrent Group. The company
specializes in cardiovascular, diabetes and central nervous system (CNS).It registered an 18.1% and 19.1% CAGR in sales
and PAT over FY2009-18. Torrent Pharma has also delivered 3-year average
ROE of 29.4%. Hence Buy

Download Full Report View Full Report in Browser